{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:23:05Z","timestamp":1791397385400,"version":"4.3.3"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.critrevonc.2008.06.012","type":"journal-article","created":{"date-parts":[[2008,8,7]],"date-time":"2008-08-07T09:09:36Z","timestamp":1218100176000},"page":"264-271","source":"Crossref","is-referenced-by-count":63,"title":["Angioimmunoblastic T-cell lymphoma"],"prefix":"10.1016","volume":"68","author":[{"given":"Emilio","family":"Iannitto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s J.M.","family":"Ferreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Minardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Tripodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans H.","family":"Kreipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2008.06.012_bib1","series-title":"Pathology & genetics","first-page":"135","article-title":"Tumours of haematopoietic and lymphoid tissue","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2005-03-1083","article-title":"Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells?","volume":"106","author":"Grogg","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib3","first-page":"627","article-title":"Angioimmunoblastic lymphadenopathy with dysproteinemia","volume":"20","author":"Freter","year":"1993","journal-title":"Semin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V79.7.1789.1789","article-title":"Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma","volume":"79","author":"Weiss","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.194.7.927","article-title":"Survival and clonal expansion of mutating \u201cforbidden\u201d (immunoglobulin receptor-deficient) Epstein-Barr virus-infected b cells in angioimmunoblastic t cell lymphoma","volume":"194","author":"Brauninger","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib6","first-page":"265","article-title":"The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview","volume":"81","author":"Luppi","year":"1996","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jcp.40.9.995","article-title":"Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification","volume":"40","author":"Suchi","year":"1987","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00000478-198904000-00002","article-title":"Angioimmunoblastic lymphadenopathy-type of T-cell lymphoma with a high content of epithelioid cells. Histopathology and comparison with lymphoepithelioid cell lymphoma","volume":"13","author":"Patsouris","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib9","first-page":"549","article-title":"Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy","volume":"133","author":"Feller","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1365-2141.2003.04335.x","article-title":"Angioimmunoblastic T-cell lymphoma","volume":"121","author":"Dogan","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","article-title":"Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10","volume":"99","author":"Attygalle","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib12","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood-2004-03-1206","article-title":"Unique gene expression program of human germinal center T helper cells","volume":"104","author":"Kim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2002-05-1352","article-title":"Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL","volume":"103","author":"Tsuchiya","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00000478-200401000-00005","article-title":"CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma","volume":"28","author":"Attygalle","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib15","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","article-title":"Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells","volume":"30","author":"Dupuis","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib17","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3324\/haematol.10864","article-title":"Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma","volume":"92","author":"Roncador","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib18","first-page":"392","article-title":"Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma","volume":"122","author":"Weiss","year":"1986","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib19","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1038\/sj.leu.2402642","article-title":"Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection. A different subtype of AILD-TL?","volume":"16","author":"Lome-Maldonado","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib20","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1158\/1078-0432.CCR-06-1275","article-title":"Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)","volume":"12","author":"Rodig","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/10428190601016167","article-title":"CD52 expression in non-mycotic T- and NK\/T-cell lymphomas","volume":"48","author":"Chang","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.10767","article-title":"Expression of CD52 in peripheral T-cell lymphoma","volume":"92","author":"Piccaluga","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2353\/jmoldx.2006.060016","article-title":"The frequency of B- and T-cell gene rearrangements and Epstein-Barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations","volume":"8","author":"Tan","year":"2006","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood.V72.2.413.413","article-title":"Characteristic karyotypic pattern in T-cell lymphoproliferative disorders with reactive \u201cangioimmunoblastic lymphadenopathy with dysproteinemia-type\u201d features","volume":"72","author":"Kaneko","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib25","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0002-9440(10)64141-7","article-title":"Analysis of T-cell subpopulations in T-cell non-Hodgkin's lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor-beta gene rearrangements","volume":"158","author":"Willenbrock","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00428-004-1114-1","article-title":"In angioimmunoblastic T-cell lymphoma, neoplastic T cells may be a minor cell population. A molecular single-cell and immunohistochemical study","volume":"446","author":"Willenbrock","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0002-9440(10)64770-0","article-title":"Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy","volume":"156","author":"Smith","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib28","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1182\/blood.V80.7.1804.1804","article-title":"Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type","volume":"80","author":"Anagnostopoulos","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-4608(90)90200-T","article-title":"Inv(14)(q11q32) in one of four different clones in a case of angioimmunoblastic lymphadenopathy","volume":"44","author":"Schlegelberger","year":"1990","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib30","first-page":"179","article-title":"Angioimmunoblastic lymphadenopathy with trisomy 3: the cells of the malignant clone are T cells","volume":"4","author":"Schlegelberger","year":"1990","journal-title":"Hematol Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.1996.14.2.593","article-title":"Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type [see comments]","volume":"14","author":"Schlegelberger","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib32","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib33","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","article-title":"Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation","volume":"67","author":"Piccaluga","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib34","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0140-6736(74)90553-4","article-title":"Angio-immunoblastic lymphadenopathy with dysproteinaemia","volume":"1","author":"Frizzera","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/oxfordjournals.annonc.a059281","article-title":"Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group","volume":"6","author":"Siegert","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/oxfordjournals.annonc.a059273","article-title":"Angioimmunoblastic T-cell lymphoma: new insights, but the clinical challenge remains [editorial]","volume":"6","author":"Jaffe","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib37","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.humpath.2005.05.008","article-title":"CD10 and BCL6 expression in the diagnosis of angioimmunoblastic T-cell lymphoma: utility of detecting CD10+ T cells by flow cytometry","volume":"36","author":"Yuan","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood.V82.1.241.bloodjournal821241","article-title":"B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus","volume":"82","author":"Abruzzo","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib39","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/1097-0142(197802)41:2<578::AID-CNCR2820410226>3.0.CO;2-8","article-title":"Malignant lymphoma arising in angioimmunoblastic lymphadenopathy","volume":"41","author":"Nathwani","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.thj.6200136","article-title":"Response to low-dose oral methotrexate and prednisone in two patients with angio-immunoblastic lymphadenopathy-type T-cell lymphoma","volume":"2","author":"Quintini","year":"2001","journal-title":"Hematol J"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib41","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood.V88.6.2354.bloodjournal8862354","article-title":"Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine","volume":"88","author":"Ong","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000046545","article-title":"Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine","volume":"105","author":"Tsatalas","year":"2001","journal-title":"Acta Haematol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002770050244","article-title":"Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using 2-chlorodeoxyadenosine","volume":"73","author":"Sallah","year":"1996","journal-title":"Ann Hematol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib44","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/10428199909058489","article-title":"Successful treatment with fludarabine in two cases of angioimmunoblastic lymphadenopathy with dysproteinemia","volume":"34","author":"Hast","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib45","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1023\/A:1008275208592","article-title":"Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine","volume":"8","author":"Advani","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/10428199909145744","article-title":"Successful treatment of immunoblastic lymphadenopathy-like T-cell lymphoma with cyclosporin A","volume":"35","author":"Takemori","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib47","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.leu.2403710","article-title":"Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide","volume":"19","author":"Dogan","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib48","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/10428199909058412","article-title":"Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature","volume":"32","author":"Pautier","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ijc.10758","article-title":"Angioimmunoblastic T cell lymphoma is derived from mature T-helper cells with varying expression and loss of detectable CD4","volume":"103","author":"Lee","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib51","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib52","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/labinvest.3700145","article-title":"Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression","volume":"84","author":"Zhao","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib53","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-117-5-364","article-title":"Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM\/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group","volume":"117","author":"Siegert","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib54","first-page":"1272","article-title":"Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation","volume":"88","author":"Schetelig","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib55","first-page":"892","article-title":"Recombinant human interferon-alpha in the treatment of angioimmunoblastic lymphadenopathy: results in 12 patients","volume":"5","author":"Siegert","year":"1991","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/10428190210190","article-title":"Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reports","volume":"43","author":"Strupp","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.critrevonc.2008.06.012_bib57","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2007-02-074641","article-title":"Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL prospective multicentre trial","volume":"110","author":"Gallamini","year":"2007","journal-title":"Blood"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084280800139X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084280800139X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T14:03:29Z","timestamp":1588860209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084280800139X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S104084280800139X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2008.06.012","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}